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Background: Nucleic acid amplification is the most sensitive and specific method to detect Plasmodium falciparum.
However the polymerase chain reaction remains laboratory-based and has to be conducted by trained personnel.
Furthermore, the power dependency for the thermocycling process and the costly equipment necessary for the
read-out are difficult to cover in resource-limited settings. This study aims to develop and evaluate a combination
of isothermal nucleic acid amplification and simple lateral flow dipstick detection of the malaria parasite for
point-of-care testing.
Methods: A specific fragment of the 18S rRNA gene of P. falciparum was amplified in 10 min at a constant 38°C
using the isothermal recombinase polymerase amplification (RPA) method. With a unique probe system added to
the reaction solution, the amplification product can be visualized on a simple lateral flow strip without further
labelling. The combination of these methods was tested for sensitivity and specificity with various Plasmodium
and other protozoa/bacterial strains, as well as with human DNA. Additional investigations were conducted to
analyse the temperature optimum, reaction speed and robustness of this assay.
Results: The lateral flow RPA (LF-RPA) assay exhibited a high sensitivity and specificity. Experiments confirmed a
detection limit as low as 100 fg of genomic P. falciparum DNA, corresponding to a sensitivity of approximately
four parasites per reaction. All investigated P. falciparum strains (n = 77) were positively tested while all of the
total 11 non-Plasmodium samples, showed a negative test result. The enzymatic reaction can be conducted under
a broad range of conditions from 30-45°C with high inhibitory concentration of known PCR inhibitors. A time to
result of 15 min from start of the reaction to read-out was determined.
Conclusions: Combining the isothermal RPA and the lateral flow detection is an approach to improve molecular
diagnostic for P. falciparum in resource-limited settings. The system requires none or only little instrumentation
for the nucleic acid amplification reaction and the read-out is possible with the naked eye. Showing the same
sensitivity and specificity as comparable diagnostic methods but simultaneously increasing reaction speed and
dramatically reducing assay requirements, the method has potential to become a true point-of-care test for the
malaria parasite.
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Malaria causes the most deaths worldwide of all parasitic
diseases, resulting in an estimated 660,000 casualties an-
nually. Plasmodium falciparum is with 90% of all cases
the main source for infection in humans of all Plasmo-
dium species [1]. Effective treatment and surveillance of
malaria is only possible with a reliable and sensitive
diagnostic set-up. At present, the parasite is routinely
detected by microscope techniques that require instru-
mentation and a trained eye. Also rapid diagnostic tests,
usually based on antigen detection, for point-of-care
testing are available. However these tests, like micros-
copy, often lack in sensitivity or clarity of results. Mo-
lecular techniques such as polymerase chain reaction
(PCR), which amplify a specific nucleic acid sequence,
have been developed over the past years. These methods
have the advantage that they can detect low level of
parasitaemia [2] or give additional information on the
infection in a single assay [3,4]. Nevertheless, the PCR
still remains laboratory based due to the high complexity
of the assay and the still not-far-enough advanced port-
able devices for point-of-care testing. Furthermore, the
continuous electricity dependency for the thermocycling
process and the rather expensive equipment necessary
for the PCR machinery makes it difficult to conduct this
method in resource-limited settings, which might occur
in some areas especially in developing countries and
thus is restricted to be a confirmatory technique in la-
boratory diagnostics [5].
Lately several isothermal nucleic acid amplification tech-
niques have been established which do not require the
thermocycling process but run on a constant temperature.
Examples are the loop-mediated isothermal amplification
(LAMP) for the detection of P. falciparum [6], Plasmo-
dium vivax [7] or for four species of human malaria
parasites [8] and the real-time quantitative nucleic acid
sequence based amplification (real-time QT-NASBA)
for the quantification of rRNA samples of three differ-
ent Plasmodium strains [9]. These methods drastically
simplified the assay set-up and improved the speed for
nucleic acid amplification in comparison to a standard
PCR.
A novel approach of isothermal amplification could be
demonstrated with the recombinase polymerase amplifica-
tion (RPA) [10]. This method uses two target specific
oligonucleotide primers, which are able to bind to the
template DNA with the assistance of a recombinase in
combination with strand-displacement DNA synthesis
(Figure 1A). At temperatures just above room temperature
an amplification of complex DNA targets can be achieved
in less than 30 minutes. Recently, several applications of
this method have been demonstrated for the detection of
DNA and RNA targets [10-14] and the integration of the
RPA in different instrumentations was shown [15-18].The analysis of the amplification products usually in-
volves labour-intensive and costly read-out arrangement,
for example, electrophoresis systems or sensors and op-
tics for fluorescence detection. For resource-limited set-
tings, simpler systems like lateral flow immunoassays
strips are an option. With nucleic acid lateral flow im-
munoassays (NALFIA), it is possible to detect double-
stranded amplicons, which were labelled with two differ-
ent antigenic tags during the enzymatic reaction [19]
(Figure 1B). The recognition is achieved by binding to a
tag-specific antibody on the surface at the detection line
of the lateral flow strip and by cross-linking it with a
second tag-specific antibody on colloid gold nanoparti-
cles, resulting in a coloured signal that can be semi-
quantitatively analysed with the naked eye (Figure 1C).
For the detection of the RPA amplification product a
probe-based system was used [10,17]. The development
and evaluation of a combination of isothermal RPA and
lateral flow strip detection for P. falciparum is described.
The presented test reduces the need for instrumentation
and complexity of nucleic acid amplification and gener-




Genomic DNA of in total 77 P. falciparum strains were
obtained through the Malaria Research and Reference
Reagent Resource Center (MR4) as part of the BEI
Resources Repository. Quantity and quality of the ex-
tracted DNA was determined by measuring A260 and
the ratio of A260/A280 on a Nanodrop ND-1000 spec-
trophotometer (ThermoScientific, USA). The DNA of
3D7 was adjusted to a working concentration of 1 ng/μl
in TE-buffer. Other DNAs of prokaryotic and eukaryotic
samples were extracted using the GeneJET Genomic
DNA Purification Kit (ThermoScientific, USA) and also
tested for quantity and quality.
RPA reactions in solution
For optimization and primer testing the RPA reactions
were first conducted in solution. A typical 50 μl reaction
was performed with the TwistAmp Basic kit (TwistDx,
UK) and contained 480 nM RPA primers, 1 M betaine
and 1x rehydration buffer. To start the reaction 14 mM
magnesium acetate was added. Samples were incubated
for a typical 25 min at 38°C, if not indicated otherwise, in
a Thriller thermoshaker-incubater (PEQLAB Biotechnolo-
gie GMBH, Germany) under constant shaking at 300 rpm.
Subsequent analysis on 2% agarose-gel (Agarose Broad
Range, Germany) stained with ethidium bromide was con-
ducted after purification of the samples with the QIAquick
PCR Purification Kit (Qiagen, Germany). Primers were



















Figure 1 Recombinase polymerase amplification and lateral flow detection. Reaction principle of the recombinase polymerase amplification
(RPA). The two oligonucleotide primers form a complex with the recombinase proteins (green). This complex is able invade the target DNA and
directs the primer to homologous sequences. A continuous amplification at 38°C takes place by strand-displacement synthesis catalyzed by a
DNA polymerase (red) while single-strand binding proteins (SSB) (brown) stabilize the displaced strand (A). During LF-RPA the reverse primer
carries an antigenic tag at the 5′end and a modified probe is added in the reaction. The modified probe is labelled with a different antigenic tag
at the 5′end and a 3′end polymerase blocking group. Additionally the probe contains an abasic site 30 nt downstream the 5′end. Only when the
probe fully binds to a homologous sequence the nuclease (yellow) is able to cut through the DNA double strand and release the blocking group.
Thereby additional polymerase extension substrate is generated and the continuation of strand synthesis results in a dual-labelled amplicon.
Amplification and labelling reaction run in the same tube (B). Detection of the labelled RPA amplicon on the lateral flow dipstick by binding
to tag-specific antibodies on the test strip and to tag-specific antibodies on gold nanoparticles present in the sample application area. A reddish band
is generated on the test line in a sandwich assay manner if the amplicon was successfully generated. Not captured gold particles flow over and are
fixed by species-specific antibodies on the control line (C). LF-RPA for P. falciparum using 1 ng of genomic DNA and 25 min reaction time. A
test band visible to the naked eye is formed and confirms the presence of the RPA amplicon. The control line determines the validity of the
test run. Detail enhanced for better view (D).
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http://www.ncbi.nlm.nih.gov/tools/primer-blast/ combin-
ing Primer3 and BLASTglobal alignment. All oligonucleo-
tides in this study were synthesized by biomers.net
(Germany). Various primer combinations and targets were
evaluated and one primer pair was selected during the
process: PfFwd 5′-GTGTTCATAACAGACGGGTAGTC
ATGATTGAGT-3′ and PfRev 5′-ACATCTGAATACGA
ATGCCCCCAAAGATACTCC-3′ resulting in an amplicon
with the size of 174 bp targeting a region on the small sub-
unit (SSU) (18S rRNA) gene of P. falciparum (GenBank:
JQ627152).
Lateral flow RPA assay
For the adaptation to the lateral flow detection system, a
labelling RPA was carried out. Herein, a labelling reverse
primer and a lateral flow probe were used. The labelling
primer is identical to the PfRev primer but contains a
digoxigenin (DIG) at the 5′end. The sequence of the
hybridization probe was 5′-Carboxyfluorescein - GTGT
TTGAATACTACAGCATGGAATAACAAXTATGAATA
AGCTAATTATT-Spacer C3-3′ where “X” highlights the
insertion of an abasic furan (dSpacer), which was intro-
duced in the probe sequence to mimic an abasic site. Adouble stranded DNA template is formed when the probe
binds to the antisense DNA strand. The nuclease con-
tained in the reaction solution recognizes the abasic site
and cleaves the phosphodiester bond and as a conse-
quence releases the blocking group. The polymerase is
now able to extend the probe and the amplification
process continues. In combination with the unlabelled
forward primer, a dual-labelled amplicon is generated
which can be analysed directly on the lateral flow dip-
stick (Figure 1B). The reaction conditions for the single
tube lateral flow amplification using the TwistAmp nfo kit
(TwistDx, UK) were 420 nM of forward and reverse primer,
120 nM lateral flow probe, 1x rehydration buffer and 1 M
betaine. The reaction was adjusted to 50 μl by adding
ddH2O and used for resuspending the freeze-dried pellet.
After adding the template DNA 14 mM magnesium acetate
was added to start the reaction. Samples were incu-
bated for 25 min at 38°C in a Thriller thermoshaker-
incubater (PEQLAB Biotechnologie GMBH, Erlangen,
Germany) under constant shaking at 300 rpm.
Visualization on lateral flow dipsticks
For the detection of the RPA-generated, labelled ampli-
con, Hybridetect 2 T (Milenia Biotec GmbH, Germany)
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with gold nanoparticles conjugated with polyclonal anti-
carboxyfluorescein antibodies (rabbit) contained on the
lateral flow strip at the application pad. The gold nano-
particle/amplicon – conjugate can then bind with the
3′-end to immobilize digoxigenin antibodies on the de-
tection line. A control line with immobilized anti-rabbit
antibodies serves as an assay control. Two μl of the RPA
reaction were diluted in 98 μl of tris-buffered saline.
Dipsticks were directly inserted into this dilution and
were incubated at an upright position for 5 min. Pictures
were taken in the BioDocAnalyze imagine system (Analytik
Jena AG, Germany).
Evaluation of lateral flow RPA conditions
For sensitivity testing, a dilution of genomic DNA of
P. falciparum 3D7 to 100 pg, 10 pg, 5 pg, 1 pg, 500 fg,
100 fg and 10 fg per μl was prepared in TE-buffer and
a volume of 1 μl was used per reaction. The specificity of
the LF-RPA was analysed using excess amounts of gDNA
from a panel of eukaryotic and prokaryotic organisms. At
least 10 ng of gDNA were used as template in these reac-
tions. In further experiments 50 ng of gDNA of the closely
related pathogen Toxoplasma gondii and 50 ng of human
DNA, which might be present in samples using whole-
blood extracts, where utilized for specificity testing. In
total 77 strains of P. falciparum were investigated using
1 ng of gDNA as template for the amplification. The re-
action time was determined by stopping the reaction at
1, 5, 10, 15, 20, 25 and 30 min after the addition of
magnesium acetate by immediate dilution and analysis
on the lateral flow dipsticks. The reaction conditions
for the temperature experiments were according to the
above-mentioned lateral flow RPA assay protocol with
varying temperatures ranging from 15-50°C. For inhibi-
tory experiments, 1 ng of genomic DNA of P. falcip-
arum 3D7 was used in a 50 μl RPA reaction which
contained the following inhibitory substances: SDS
(0.05% v/v), ethanol (4% v/v), heparin (0.5 U) (Sigma-
Aldrich, Germany) and haemoglobin (2 g/l; 20 g/l and
50 g/l) (Sigma-Aldrich, Germany) in which the numbers
in brackets indicate the final concentrations in these ex-
periments. Additionally, 10 μl per 50 μl reaction of whole
blood (Basis-line VB, Medichem, Germany) and serum
(Basis-line S, Medichem, Germany) was utilized for fur-
ther inhibitory tests.
Results
Establishing the lateral flow RPA
In order to establish the RPA, initial experiments were
undertaken in single tube reactions without the addition
of the probe, to screen primers and test different reac-
tion conditions. Even though the RPA has a PCR-like
set-up, PCR primers differ from RPA primers. Longeroligonucleotides are necessary to stimulate and complete
priming with support of the recombinase proteins,
therefore the designed RPA primers are typically be-
tween 30 and 35 nucleotides long. After this initial selec-
tion process a second step combined the RPA with
lateral flow detection, again with a consideration on sig-
nal strength, absence of background and sensitivity. The
probes used for lateral flow assays are 46-52 nucleotides
long and the abasic site is located 30 nucleotides
downstream of the 5′end [20]. For the detection of all
Plasmodium species several multicopy loci are known.
Most PCR methods target the 18S rRNA genes because
of the high sequence conservation and the widely
available sequence data [2,21]. Further amplification
targets with multiple copies include pfr364 [22], stevor,
rif [23] and mitochondrial DNA sequences [24]. These
sequences have been demonstrated to be more sensi-
tive and show an even faster amplification due to the
higher number of repeats in the genome. Different
primers and probes targeting several multicopy loci of
P. falciparum were screened and as a result a primer
pair and probe targeting the 18S rRNA was chosen and
used in the follow-up experiments. In Figure 1D the result
of a lateral flow RPA (LF-RPA) using 1 ng of P. falciparum
3D7 gDNA is depicted. In this example the reaction time
was 25 min of amplification at 38°C and an additional
5 min of incubation of the lateral flow dipstick. A clearly
visible reddish band at the test line is observed while in
the negative control no band is noticeable. The control
band on both dipsticks indicates a valid test run. Primer
and probes were designed to detect all Plasmodium spe-
cies by their ribosomal RNA genes but for subclassifica-
tion purposes, another target sequence might be more
favourable. Also other multicopy targets might increase
sensitivity and reaction speed but with the straightforward
set-up of the LF-RPA the method can be adapted to other
gene sequences.
Sensitivity of the LF-RPA assay
The detection threshold of the LF-RPA was determined
by using a dilution series of P. falciparum 3D7 ranging
from 1 ng to 10 fg DNA per reaction. Additionally, the
RPA reaction was tested for sensitivity without lateral
flow probe by subsequent visualization with agarose gel
electrophoresis. The method was found highly sensitive
with detection limits of 100 fg and 500 fg, respectively,
corresponding to approximately four and 20 parasites/
reaction (Figure 2). In contrast to LAMP-based amplifi-
cation techniques with its ladder-like pattern of prod-
ucts, the RPA amplicon can be directly identified by the
specific size of the band on the agarose gel (Figure 2A).
The instrument-free detection on the lateral flow dip-
sticks revealed a higher sensitivity than the agarose
gel-based detection (Figure 2B). This finding supports
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Figure 2 Reaction sensitivity of the recombinase polymerase amplification. A serial dilution of genomic DNA from P. falciparum 3D7 was
used to test the analytical sensitivity of the assay. Positive RPA reaction products (174 bp) can be detect on a stained agarose gel (2%) (A). In the
lateral flow format (LF-RPA) the sensitivity was 100 fg of genomic DNA (B). NTC: no template controls contained water.
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immunoassay in combination with PCR, demonstrates
lower or similar detection limits in comparison to gel
electrophoresis analysis [25,26]. Moreover the use of
probe during the LF-RPA reaction provides an add-
itional starting point for polymerase elongation by
functioning as primer upon binding to the target se-
quence. Especially with low amounts of starting DNA,
this might increase the amplification time and sensitiv-
ity of the reaction. The reactions performed to deter-
mine the sensitivity of the LF-RPA were constantly
shaken during the amplification. In particular when
working with DNA template concentrations close to
the limit of detection, a constant shaking results in
more stable signals on the test strips than with the rec-
ommended single flicking/shaking event. When the
shaking is completely omitted a reduced sensitivity and
reaction efficiency of the assay can be observed. For
the development of a POCT test this has to be taken
into account in order to enable the best performance
of the amplification reaction. However, the LF-RPA has
a lower limit of detection comparable to nested PCR
methods for P. falciparum and surpasses the analytical
sensitivity of malaria microscopy of thin films (200
parasites/μl) [27] and rapid diagnostic tests (RDTs)
(>100 parasites/μl) [28] attesting that even low levels
of parasitaemia can be detected with this method in a
convenient lateral flow immunoassay.
Specificity of LF-RPA detection
In total, 77 P. falciparum and 11 non-Plasmodium
DNAs were investigated in the LF-RPA experiments
(Additional file 1: Table S1). All P. falciparum samples
were correctly identified by a clearly visible band on the
lateral flow strip (Additional file 1: Figures S1-S3). Dif-
ferent non-Plasmodium DNAs from prokaryotic and
eukaryotic organisms were tested in cross-detection
studies using an excessive amount of DNA. These tests
included organisms such as Rickettsia sibirica which
may cause symptoms similar to malaria and the closely
related protozoan Toxoplasma gondii. In further experi-
ments 50 ng of human DNA was used as template inthe LF-RPA reaction in order to simulate the potential
effect of background genomic human DNA which may
be present in patient samples. The LF-RPA did not de-
tect any of the tested negative DNA samples. The pre-
liminary results, with a specificity of 100%, suggests that
the RPA is a highly specific method and comparable to
PCR or LAMP techniques [29]. The RPA primers used
in this study were designed to detect P. falciparum only,
since the initial test development focused on this species
as the main cause for infection in humans. Future stud-
ies with other Plasmodium species, which are also rele-
vant for human infections in tropical and subtropical
regions, e.g. P. vivax, P. ovale, P. malariae and P. know-
lesi, have to further verify the specificity of the assay.
Additional tests with clinical patient samples and in-field
use have to prove the effectiveness of this method as
point-of-care test for the malaria parasite as well as in
combination with different sample preparation methods.
Temperature optimum
The use of isothermal nucleic acid amplification methods
eliminates the need for the thermocyling process necessary
in the PCR. Only one constant temperature has to be ap-
plied with a temperature optimum of the RPA at 37-42°C.
The LF-RPA was tested using 1 ng of gDNA in different
temperature settings and found that the assay works
well in a wide range of temperatures from 30-45°C,
suggesting that the LF-RPA is not sensitive to gradients
or small aberration in the temperature profile during
the reaction (Figure 3A). The presented experiments
were conducted in a Thriller-thermoincubator but the
results show that the experiments could also be exe-
cuted in a waterbath or, if no instrumentation is avail-
able, even by body heat. According to the supplier, the
amplification reaction takes place at room temperature,
albeit slower. The experiments carried out during this
study did not affirm this statement since a clearly vis-
ible band on the dipstick appeared only at temperatures
above 30°C. With further primer optimization and
modified probes it may be possible to adapt the LF-
RPA to lower temperatures. Many isothermal nucleic
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Figure 3 Determination of reaction temperature and time. The LF-RPA works effectively in a broad range of constant reaction temperatures
(A). After 10 min of isothermal amplification reaction, the test line is visible on the test strip. Including the incubation of 5 min the whole assay
time of the LF-RPA is less than 20 min (B).
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Using a comparatively lower temperature, the power
consumption for diagnostic tests can be further re-
duced by the LF-RPA, which, in combination with the
stability of the reaction in different temperature set-
tings, facilitates the field use.
Reaction time
The LF-RPA assay can be performed in less than 20 min
(Figure 3B). A signal on the lateral flow dipstick can be
detected after 10 min of amplification reaction at 38°C
and 5 min of incubation, although the band is weaker in
comparison to longer amplification times. Higher
amounts of template (in the experiment shown 1 ng of
genomic DNA was used) lead to a stronger signal even
at shorter reaction times. An incubation period of 5 min
for the lateral flow was chosen in order to assess all tests
evenly. In most experiments the signal occurred faster
and it may be possible to further reduce the overall assay
time by an earlier read-out. In comparison to other diag-
nostic tests for malaria, the LF-RPA is a very rapid test,
assuming that microscopy, qPCR and LAMP usually
take more than one hour to complete in a laboratory set-
ting. With its simple two-step procedure, where the first
step is the reaction itself and the second step is the dilu-
tion and visualization on the lateral flow strip, the LF-
RPA requires lesser hands-on time and in contrast to
microscopy the procedure can be easily trained. Further-
more, the dried format of the reaction components is
uncomplicated to handle and the on-site testing with an
immediate read-out without further preparation steps
and instrumentation eliminates sample shipment and re-
duces overall operator time. The use of a closed and po-
tentially automated system, e.g., a microfluidic device,
could avoid cross contamination and further simplify the
handling procedure.
Inhibitory effect
Numerous substances are known to interfere with the
enzymatic nucleic acid amplification. These substancescan either be present in the biological sample or be in-
troduced during preparation or the sampling process.
Especially in resource-limited settings, a uniform sam-
pling and handling might not be guaranteed. The
screening for malaria is usually performed directly with
blood samples or collected and stored samples are used
in the form of dried blood spots for a later analysis.
Blood does contain numerous potential PCR inhibitors
[30], e.g., haemoglobin, lactoferrin and immunoglobulin
G. Anticoagulants, used to prevent the clogging of blood
samples, have an influence on the efficiency of the en-
zymatic amplification [31] as well as residues of sub-
stances used for sample lysis (e.g. detergents) [32],
nucleic acid extraction and purification (e.g., salts, EtOH,
phenol). Interference factors may hinder the enzymatic
amplification reaction by direct interaction with the en-
zymes or by interfering with cofactors required for the
enzymatic activity. In addition, a direct binding to the
DNA could possibly hamper the strand synthesis by the
polymerase. For the LF-RPA, several of the potential in-
hibitory substances that may be present in samples
tested for P. falciparum were tested by spiking target
DNA in a complex sample matrix or by adding interfer-
ing components to the reaction. In all cases a higher in-
hibitory concentration compared to known literature
values for the standard Taq Polymerase were determined
(Figure 4). Haemoglobin seems to have no influence on
a successful LF-RPA reaction in high concentrations. No
full inhibition of the reaction was observed when 50 g/l
of haemoglobin or ethanol (4% v/v) was present in the
assay. At template concentrations close to the limit of
detection a maximum reduction of a tenfold in sensitiv-
ity was noticed (Additional file 1: Figure S4). The anti-
coagulant heparin (0.5 U) had not effect on the reaction
while high amounts of detergent (SDS) inhibited the
amplification.
The reaction was also tested by spiking 1 ng of gDNA
of P. falciparum in human serum and human whole
blood and used it for the LF-RPA. While blood serum
could be directly used as matrix for a highly sensitive
control
test
Figure 4 Inhibitory experiments with lateral flow recombinase polymerase amplification. A successful amplification and detection on the
lateral flow dipstick was achieved even when high concentration of known PCR inhibitors and possible contaminants from preparation steps are
present in the reaction. The LF-RPA can be carried out directly in serum samples.
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lification in whole blood samples was not effective. The
reason for this could be the anticoagulant sodium fluor-
ide (NaF) which was used in this experiment or further
components in whole blood which interfere in the RPA
but are not yet determined. However, these preliminary
results show that the LF-RPA might be more stable than
common PCR systems, which would be suitable for the
point-of-care setting and potentially requires only mini-
mum clean-up and sample preparation steps. A reduced
demand on preparation instrumentation would also
lessen the handling time and decrease the costs for the
overall diagnostic testing.
Conclusions
Current diagnostic methods to detect P. falciparum suf-
fer from a delayed time-to-result by either the reaction
mechanism of the used technique or the prolonged
period of time for the shipment and storage of samples
to a distant, centralized laboratory. Furthermore, trained
personnel are necessary to conduct the diagnostics, espe-
cially in microscopic examination but also with nucleic acid
amplification-based methods where the handling of com-
plex equipment is required. The PCR remains the usual
laboratory-bound technique, although the obvious advan-
tages of the use of nucleic acid amplification methods are
the sensitivity and specific identification of the pathogen.
In this study the use of the isothermal RPA in combin-
ation with a lateral flow detection format was demon-
strated. The RPA amplifies a specific target sequence at
a constant reaction temperature with the support of a
recombinase and a strand-displacement polymerase. The
use of a special probe structure and the nuclease enzyme
results in a dual-tagged DNA amplicon in a single tube
reaction, which can be detected on the lateral flow strip.
An assay for the detection of P. falciparum was estab-
lished and the specificity of this LF-RPA method was de-
termined by testing different Plasmodium strains and
non-related target samples. Also the sensitivity of thismethod was found to be comparable to conventional
PCR methods and is able to detect even low levels of
parasitaemia. Additional benefits of this method are the
constant low temperature necessary to conduct the amp-
lification which, depending on the place used, might be
only slightly above the surrounding temperature and the
fast reaction speed from start of reaction to the analysis
on the dipstick in less than 20 min. Furthermore the LF-
RPA can tolerate inhibitory substances and temperature
variations. Both steps of the LF-RPA, the reaction itself
and the analysis on the lateral flow immunoassay, do not
require any or only little instrumentation which is ideal
for point-of-care testing and also results in overall lower
diagnostic costs. An easily visible band on the lateral
flow strip gives a clear yes/no answer that can be read
by the naked eye and by untrained personnel. This is es-
pecially important in remote areas where potentially no
trained healthcare worker is available. Additional tests of
the LF-RPA in-field and in resource-limited settings have
to prove the effectiveness of this method as a point-of-
care test for the malaria parasite and further assess the
reaction conditions. Especially a comparison with stand-
ard diagnostic tests and investigations with individual
sample collection and preparation needs to be conducted
in future studies. Also the use of a closed and potentially
automated system, e.g., a microfluidic device comprising
sample preparation to analyse either saliva or blood sam-
ples, is being considered to avoid cross contamination and
to further simplify the handling procedure. With the
PCR-like reaction scheme utilizing only two primers in
the reaction, the system can be easily adapted to other
DNA target sequences and also has the option to estab-
lish a multiplex reaction to potentially gain more infor-
mation, e.g., subclassifications, from one sample or to
establish a positive reaction control.
In summary, the LF-RPA is a practical, yet simple-to-
conduct method where none or only little instrumentation
is necessary. This fast and easy to read-out system could
be useful as a rapid point-of-care-test to monitor malaria
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low-grade reservoirs at an early stage of the infection.
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